NCT01126749 2022-02-28Eribulin Mesylate Administered in Combination With Gemcitabine Plus Cisplatin Versus Gemcitabine Plus Cisplatin Alone as First-Line Therapy for Locally Advanced or Metastatic Bladder CancerEisai Inc.Phase 1/2 Terminated92 enrolled 15 charts